about
The evolution of poxvirus vaccinesVaxvec: The first web-based recombinant vaccine vector database and its data analysisGene Therapies for Cancer: Strategies, Challenges and Successes.Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized TrialsConstruction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens.Recent advances and future of immunotherapy for glioblastoma.Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses.Vaccines: A review of immune-based interventions to prevent and treat disease.Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: Potential utility and limitations.Recent outbreaks of highly pathogenic avian influenza viruses in South Korea.Multivalent and Multipathogen Viral Vector Vaccines.Vaccines against Botulism.Microneedle-mediated delivery of viral vectored vaccines.Proof-of-concept for a virus-induced obesity vaccine; vaccination against the obesity agent adenovirus 36.Arenaviral vaccine vectors to combat infectious diseases.Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens.Systemically Administered Sindbis Virus in Combination with Immune Checkpoint Blockade Induces Curative Anti-tumor Immunity.
P2860
Q26995905-58950D10-1561-4D6B-93FE-BDB5FE2A95E2Q30996881-75B7EF48-1E9A-4435-8AB5-6A75A35845D6Q35186312-9DF08BB9-2CF1-49C0-865D-24D2DC5A34C2Q35762443-048DA1D6-C2D6-4EFF-9D3E-1693A8D9AD47Q35944742-3FE8895C-7B8C-4392-AD93-ADBB0F3E6674Q37239071-9DD9FB30-9B39-4298-9682-1805C255AB68Q37419985-4CCDF9BB-FFD8-4E0C-BF40-70C19EBF8C75Q38364468-97C6FEAE-C2CE-4FBE-8206-20CD7FCA8388Q38540633-762886FA-2F00-4C45-B884-45DB58107918Q38647070-A25FFCFF-509E-402D-A001-3D14B5429840Q38830323-00B2BF5C-8270-431B-BEFF-4AAA14B8BAD2Q40059125-26633C02-EEC3-49C7-9DAC-73262FE8431AQ40596089-F5A80D36-E9F4-44B6-9F3F-8856D1C4A1F8Q42232577-112845AA-7BBF-44D1-AC4C-B5DC9C784816Q42333574-F60486B6-62C3-426B-9C0D-45E063396A5CQ47137438-9AB75DD0-1CD6-4084-B3D9-21EDDF9B0754Q55516226-F9686A2F-3276-4EBE-9CF8-4FFC47A5DE69
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Viral vectors for vaccine applications.
@en
type
label
Viral vectors for vaccine applications.
@en
prefLabel
Viral vectors for vaccine applications.
@en
P2860
P356
P1476
Viral vectors for vaccine applications.
@en
P2093
Youngjoo Choi
P2860
P304
P356
10.7774/CEVR.2013.2.2.97
P577
2013-07-03T00:00:00Z